Warfarin Sodium, amorphous

Warfarin Sodium, amorphous; API; EP, USP, JP, ANVISA; [129-06-6]
Web icon

Description

Warfarin Sodium, amorphous is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads [129-06-6]. It is used to treat or prevent blood clots in veins or arteries, which can reduce the risk of stroke, heart attack, or other serious conditions. Detailed specification, Certificate of Analysis and samples are available on request. Warfarin sodium is a 4-hydroxycumarin, these are known as vitamin K antagonists. Vitamin K antagonists are anticoagulants that encroach on the blood clotting cascade. Since the substance can have significant fluctuations in its effectiveness, depending on the genotype, the blood clotting levels for dose tuning should be tested regularly.

  • Pharmaceutical products
  • warfarin
  • anticoagulant
  • heart attack

Product characteristics

CAS
129-06-6
Product Information
API
Route of Synthesis
Synthetic
Patent Expiry
EU, US - expired
Indication
Anticoagulant, Tromboembosism
Dosage
Oral and iv formulation

Domain icon Manufacturer/ Producer

55218 Ingelheim - Germany

Contact